Pharma Times

NOVEMBER 17, 2020

Companies will develop oral small molecule treatments

146

146

NY Times

NOVEMBER 18, 2020

The company said it planned to apply for emergency approval from the Food and Drug Administration “within days.

Vaccines 145

Vaccines 145

pharmaphorum

NOVEMBER 20, 2020

COVID-19 has turned the world on its head and healthcare systems have had to respond rapidly to match the sudden changes created by lockdown. Digital health had already been building a presence before the pandemic, but the tools it offers have been essential to counter the disruption caused by the coronavirus, reports Richard Staines. COVID-19 isn’t going away any time soon but when, and if, this crisis subsides the healthcare systems that are left behind will have changed radically.

121

121

Pharma Marketing Network

NOVEMBER 19, 2020

The COVID-19 pandemic has undoubtedly accelerated disruption within the digital world. Out of this heavy disruption comes an opportunity for companies to become more innovative-focused and show how quickly they can pivot under pressure. Right now, the pharmaceutical industry is adapting faster than ever before in their marketing strategies due to reduced drug rep access, a (mostly) digital shift, and new and emerging digital and virtual platforms.

Physician Offices 98

Physician Offices Communication 98

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

NOVEMBER 16, 2020

It is hoped that the move will help to tackle the persistent symptoms – such as fatigue and brain fog – suffered by people who have developed the condition

142

142

pharmaphorum

NOVEMBER 20, 2020

Doctors in the US are to get another option to treat COVID-19 after the FDA granted an Emergency Use Authorization (EUA) for Eli Lilly’s baricitinib. Baricitinib is the active ingredient in Lilly’s rheumatoid arthritis drug Olumiant and is the latest example of a drug being repurposed to combat COVID-19. Most of the drugs attempt to tackle the inflammation that can cause complications in patients with severe disease.

Hospitals 119

Hospitals 119

Drug Patent Watch

NOVEMBER 15, 2020

Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…. The post New patent for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Pharma Times

NOVEMBER 20, 2020

Service also offers price comparison on generic and branded drugs

Online Pharmacies 140

Online Pharmacies 140

NY Times

NOVEMBER 16, 2020

Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.

Vaccines 105

Vaccines 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

NOVEMBER 17, 2020

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. It can help address well established issues with studies, such as patient recruitment and retention, as well as reducing the need for additional trial protocol amendments.

Documentation 116

Documentation Pharmaceutical Companies Pharmaceutical Companies Hospitals 116

Outsourcing Pharma

NOVEMBER 18, 2020

The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.

98

98

Pharma Times

NOVEMBER 17, 2020

MPs launch inquiry with view of securing extra support for sector

137

137

NY Times

NOVEMBER 20, 2020

A large team of regulators at the agency will take about three weeks to review an application spanning thousands of pages.

Vaccines 103

Vaccines 103

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

NOVEMBER 19, 2020

The FDA has agreed to expedite development of two rare disease drugs from Sanofi. The most significant of the two announcements is the Priority Review for avalglucosidase alfa, a potential new therapy for Pompe disease. The review period will be shortened from the standard ten months to six months or less, and the French pharma said the FDA will make the regulatory decision before May 18th.

Immunization 105

Immunization Immunity 105

Outsourcing Pharma

NOVEMBER 18, 2020

A leader from the trial patient services specialist discusses the importance of keeping the participantâs vital role top of mind in research studies.

89

89

Pharma Times

NOVEMBER 17, 2020

Drug combinations tested were found to be well tolerated

136

136

Eye on FDA

NOVEMBER 17, 2020

Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. Last week Pfizer and BioNTech announced findings from the first interim analysis of the Phase III studies of their candidate vaccine for COVID-19 demonstrating high efficacy levels followed this week by a similar announcement by Moderna.

Communication 81

Communication Vaccines HIPAA Documentation 81

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

NOVEMBER 19, 2020

The coronavirus vaccine being developed by Oxford University and AstraZeneca produces a strong immune response in higher risk older patients, a study has found. The phase 2/3 trial results published in The Lancet about the UK-developed shot follow more detailed findings from Pfizer/BioNTech showing that their vaccine protected 94% of adults over 65 years old.

Vaccines 105

Vaccines Immunity Immunization 105

NY Times

NOVEMBER 18, 2020

The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.

Vaccines 76

Vaccines 76

Pharma Times

NOVEMBER 19, 2020

New findings from phase 2 study published in The Lancet

Immunity 130

Immunity Immunization Vaccines 130

Outsourcing Pharma

NOVEMBER 18, 2020

A leader from the CRO discusses how the COVID-19 pandemic has accelerated decentralized adoption, and how such trials lead to benefits for participants.

76

76

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 18, 2020

Pfizer is preparing to file its COVID-19 vaccine after a trial reached the safety milestone required by US regulators for emergency use, according to press reports. The company’s CEO Albert Bourla said that the company is preparing to submit its data to the FDA following last week’s announcement that the vaccine is more than 90% effective, according to an interim analysis of a phase 3 trial.

Vaccines 105

Vaccines Hospitals 105

NY Times

NOVEMBER 17, 2020

The Gallup survey held promise for an eventual vaccine rollout, but its authors cautioned that confidence remained lower than it was earlier in the pandemic.

Vaccines 74

Vaccines 74

Pharma Times

NOVEMBER 18, 2020

Designation is based on results from phase IIb/III HPTN 083 trial

130

130

Outsourcing Pharma

NOVEMBER 17, 2020

A leader from the global CRO talks about how use of RWE in clinical trials can benefit research sites and sponsors, and satisfy regulatory requirements.

66

66

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.